Fordyce Marshall's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Nov 15, 2024
- Accession no.
- 0001415889-24-026944
- Filed
- Nov 15, 2024
- Trade date
- Nov 13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 18 non-derivative transactions and 6 derivative transactions. Open-market sales total $1.52M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fordyce MarshallCIK 0001859453 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +12,218 | $2.90 | +$35,432.2 | 98,160 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −12,218 | $49.54 | −$605,279.72 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +3,307 | $2.90 | +$9,590.3 | 89,249 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −3,307 | $50.28 | −$166,275.96 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +100 | $2.90 | +$290 | 86,042 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −100 | $51.20 | −$5,120 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +1,565 | $2.90 | +$4,538.5 | 87,507 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −1,565 | $49.59 | −$77,608.35 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +310 | $2.90 | +$899 | 86,252 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −310 | $50.35 | −$15,608.5 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +1,875 | $2.90 | +$5,437.5 | 87,817 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −1,875 | $49.57 | −$92,943.75 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +1,875 | $2.90 | +$5,437.5 | 87,817 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −1,875 | $49.52 | −$92,850 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +1,875 | $2.90 | +$5,437.5 | 87,817 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −1,875 | $49.50 | −$92,812.5 | 85,942 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +7,500 | $2.90 | +$21,750 | 93,442 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −7,500 | $49.00 | −$367,500 | 85,942 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −15,625 | $0.00 | $0 | 753,587 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −1,875 | $0.00 | $0 | 751,712 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −1,875 | $0.00 | $0 | 749,837 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −1,875 | $0.00 | $0 | 747,962 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −1,875 | $0.00 | $0 | 746,087 | Direct | |
| Nov 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 738,587 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.